265 related articles for article (PubMed ID: 27080352)
1. MANAGEMENT OF ENDOCRINE DISEASE: Recurrence or new tumors after complete resection of pheochromocytomas and paragangliomas: a systematic review and meta-analysis.
Amar L; Lussey-Lepoutre C; Lenders JW; Djadi-Prat J; Plouin PF; Steichen O
Eur J Endocrinol; 2016 Oct; 175(4):R135-45. PubMed ID: 27080352
[TBL] [Abstract][Full Text] [Related]
2. Long-term evaluation following resection of apparently benign pheochromocytoma(s)/paraganglioma(s).
van Heerden JA; Roland CF; Carney JA; Sheps SG; Grant CS
World J Surg; 1990; 14(3):325-9. PubMed ID: 1973322
[TBL] [Abstract][Full Text] [Related]
3. Long-term postoperative follow-up in patients with apparently benign pheochromocytoma and paraganglioma.
Amar L; Fassnacht M; Gimenez-Roqueplo AP; Januszewicz A; Prejbisz A; Timmers H; Plouin PF
Horm Metab Res; 2012 May; 44(5):385-9. PubMed ID: 22351478
[TBL] [Abstract][Full Text] [Related]
4. Predictors of recurrence of pheochromocytoma and paraganglioma: a multicenter study in Piedmont, Italy.
Parasiliti-Caprino M; Lucatello B; Lopez C; Burrello J; Maletta F; Mistrangelo M; Migliore E; Tassone F; La Grotta A; Pia A; Reimondo G; Giordano R; Giraudo G; Piovesan A; Ciccone G; Deandreis D; Limone P; Orlandi F; Borretta G; Volante M; Mulatero P; Papotti M; Aimaretti G; Terzolo M; Morino M; Pasini B; Veglio F; Ghigo E; Arvat E; Maccario M
Hypertens Res; 2020 Jun; 43(6):500-510. PubMed ID: 31586159
[TBL] [Abstract][Full Text] [Related]
5. Posterior mediastinal paraganglioma with bilateral adrenal pheochromocytoma.
Kwon HJ; Park JH; Jin GY; Chung MJ; Lim ST; Kim MH; Kim HJ; Lee YC
Respir Med; 2004 Jun; 98(6):574-6. PubMed ID: 15191044
[TBL] [Abstract][Full Text] [Related]
6. Endoscopic treatment of solitary, bilateral, multiple, and recurrent pheochromocytomas and paragangliomas.
Walz MK; Peitgen K; Neumann HP; Janssen OE; Philipp T; Mann K
World J Surg; 2002 Aug; 26(8):1005-12. PubMed ID: 12045858
[TBL] [Abstract][Full Text] [Related]
7. Surgical Treatment of Malignant Pheochromocytoma and Paraganglioma: Retrospective Case Series.
Strajina V; Dy BM; Farley DR; Richards ML; McKenzie TJ; Bible KC; Que FG; Nagorney DM; Young WF; Thompson GB
Ann Surg Oncol; 2017 Jun; 24(6):1546-1550. PubMed ID: 28058556
[TBL] [Abstract][Full Text] [Related]
8. Paraganglioma: not just an extra-adrenal pheochromocytoma.
Laird AM; Gauger PG; Doherty GM; Miller BS
Langenbecks Arch Surg; 2012 Feb; 397(2):247-53. PubMed ID: 22086065
[TBL] [Abstract][Full Text] [Related]
9. Clinical spectrum and outcome of functional extraadrenal paraganglioma.
O'Riordain DS; Young WF; Grant CS; Carney JA; van Heerden JA
World J Surg; 1996 Sep; 20(7):916-21; discussion 922. PubMed ID: 8678971
[TBL] [Abstract][Full Text] [Related]
10. Laparoscopic resection of periadrenal paraganglioma in a patient with multiple endocrine neoplasia type 2A.
Nomura T; Takahashi M; Ando T; Sato F; Fujii S; Mimata H
Surg Laparosc Endosc Percutan Tech; 2011 Feb; 21(1):e31-3. PubMed ID: 21304370
[TBL] [Abstract][Full Text] [Related]
11. Epidemiology and Prognosis of Pheochromocytoma/Paraganglioma in Korea: A Nationwide Study Based on the National Health Insurance Service.
Kim JH; Moon H; Noh J; Lee J; Kim SG
Endocrinol Metab (Seoul); 2020 Mar; 35(1):157-164. PubMed ID: 32207276
[TBL] [Abstract][Full Text] [Related]
12. Pheochromocytoma and paraganglioma in children: a review of medical and surgical management at a tertiary care center.
Pham TH; Moir C; Thompson GB; Zarroug AE; Hamner CE; Farley D; van Heerden J; Lteif AN; Young WF
Pediatrics; 2006 Sep; 118(3):1109-17. PubMed ID: 16951005
[TBL] [Abstract][Full Text] [Related]
13. Interleukin-6 producing pheochromocytoma/paraganglioma: case series from a tertiary referral centre for pheochromocytomas and paragangliomas.
Meijs AC; Schroijen MA; Snel M; Corssmit EPM
J Endocrinol Invest; 2021 Oct; 44(10):2253-2259. PubMed ID: 33715142
[TBL] [Abstract][Full Text] [Related]
14. [Diagnosis and surgical treatment of extra-adrenal pheochromocytoma].
Hiller WF; Scheumann GF; Dralle H
Chirurg; 1993 Jan; 64(1):36-42. PubMed ID: 8436047
[TBL] [Abstract][Full Text] [Related]
15. Local-Regional Recurrence of Pheochromocytoma/Paraganglioma: Characteristics, Risk Factors and Outcomes.
Cui Y; Ma X; Gao Y; Chang X; Chen S; Lu L; Tong A
Front Endocrinol (Lausanne); 2021; 12():762548. PubMed ID: 34899602
[TBL] [Abstract][Full Text] [Related]
16. Recurrence Rate of Sporadic Pheochromocytomas After Curative Adrenalectomy: A Systematic Review and Meta-analysis.
Holscher I; van den Berg TJ; Dreijerink KMA; Engelsman AF; Nieveen van Dijkum EJM
J Clin Endocrinol Metab; 2021 Jan; 106(2):588-597. PubMed ID: 33125073
[TBL] [Abstract][Full Text] [Related]
17. Impact of Surgical Resection of the Primary Tumor on Overall Survival in Patients With Metastatic Pheochromocytoma or Sympathetic Paraganglioma.
Roman-Gonzalez A; Zhou S; Ayala-Ramirez M; Shen C; Waguespack SG; Habra MA; Karam JA; Perrier N; Wood CG; Jimenez C
Ann Surg; 2018 Jul; 268(1):172-178. PubMed ID: 28257320
[TBL] [Abstract][Full Text] [Related]
18. Local recurrence and metastatic disease in pheochromocytomas and sympathetic paragangliomas.
Araujo-Castro M; García Sanz I; Mínguez Ojeda C; Hanzu F; Mora M; Vicente A; Blanco Carrera C; de Miguel Novoa P; López García MDC; Lamas C; Manjón-Miguélez L; Del Castillo Tous M; Rodríguez de Vera P; Barahona San Millán R; Recasens M; Tomé Fernández-Ladreda M; Valdés N; Gracia Gimeno P; Robles Lazaro C; Michalopoulou T; Álvarez Escolá C; García Centeno R; Barca-Tierno V; Herrera-Martínez AD; Calatayud M
Front Endocrinol (Lausanne); 2023; 14():1279828. PubMed ID: 38155946
[TBL] [Abstract][Full Text] [Related]
19. Perioperative outcomes of syndromic paraganglioma and pheochromocytoma resection in patients with von Hippel-Lindau disease, multiple endocrine neoplasia type 2, or neurofibromatosis type 1.
Butz JJ; Yan Q; McKenzie TJ; Weingarten TN; Cavalcante AN; Bancos I; Young WF; Schroeder DR; Martin DP; Sprung J
Surgery; 2017 Dec; 162(6):1259-1269. PubMed ID: 28919049
[TBL] [Abstract][Full Text] [Related]
20. Clinical risk factors for malignancy and overall survival in patients with pheochromocytomas and sympathetic paragangliomas: primary tumor size and primary tumor location as prognostic indicators.
Ayala-Ramirez M; Feng L; Johnson MM; Ejaz S; Habra MA; Rich T; Busaidy N; Cote GJ; Perrier N; Phan A; Patel S; Waguespack S; Jimenez C
J Clin Endocrinol Metab; 2011 Mar; 96(3):717-25. PubMed ID: 21190975
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
